Institutional BioSafety Committee (IBC)

The mission of the Duke University IBC is to:

1) Ensure that all recombinant DNA research conducted at the institution or sponsored by the institution is conducted in compliance with the National Institutes of Health Recombinant DNA Guidelines, and

2) Ensure that protocols of research involving Select Agents (defined by the Centers for Disease Control and Prevention), including but not limited to recombinant DNA, are reviewed and found to comply with all national, state, and local requirements.

3) Ensure that all laboratory work conducted at Biosafety Level 3 containment or Animal Biosafety Level 3 is reviewed and found to comply with all national, state, and local requirements.

4) Respond to requests from other institutional entities (e.g., Employee Occupational Health and Wellness, Division of Laboratory Animal Resources) or individuals for other types of biosafety review.

Scheduled Meetings for 2011

Scheduled Meetings for 2012

The Duke IBC membership includes individuals representing a variety of scientific disciplines.  This diverse group was selected to provide the appropriate oversight of the various types of rDNA research conducted at Duke.  The Committee is currently co-chaired by Dr. Wayne Thomann, Assistant Clinical Professor, Dept. of Community & Family Medicine, Director, Occupational & Environmental Safety, and Dr. Richard Frothingham, Associate Professor, Dept. of Medicine - Infectious Diseases, Safety Officer, Human Vaccine Institute. 

Please feel free to contact either co-chair with questions:

Dr. Thomann
Ph: 919-684-6320
thoma010@mc.duke.edu

Dr. Frothingham
Ph: 919-684-5455
froth004@mc.duke.edu